N-terminal Region of CCAAT/Enhancer-binding Protein ε Is Critical for Cell Cycle Arrest, Apoptosis, and Functional Maturation during Myeloid Differentiation

被引:33
作者
Nakajima, Hideaki [1 ]
Watanabe, Naohide [3 ]
Shibata, Fumi [4 ]
Kitamura, Toshio [4 ]
Ikeda, Yasuo [2 ]
Handa, Makoto [3 ]
机构
[1] Univ Tokyo, Inst Med Sci, Ctr Excellence, Minato Ku, Tokyo 1088639, Japan
[2] Keio Univ, Sch Med, Dept Internal Med, Div Hematol, Tokyo 1608582, Japan
[3] Keio Univ, Sch Med, Dept Transfus & Cell Therapy, Tokyo 1608582, Japan
[4] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Cellular Therapy, Tokyo 1088639, Japan
关键词
D O I
10.1074/jbc.M600575200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CCAAT/enhancer-binding protein epsilon (C/EBP epsilon) plays a critical role in terminal myeloid differentiation. Differentiation is an integrated process of cell cycle arrest, morphological change, functional maturation, and apoptosis. However, the molecular networks underlying these events in C/EBP epsilon-induced differentiation remain poorly understood. To reveal these mechanisms, we performed a detailed molecular analysis of C/EBP epsilon-induced differentiation using an inducible form of C/EBP epsilon. The activation of C/EBP epsilon induced growth arrest, morphological differentiation, the expression of CD11b and secondary granule proteins, and apoptosis in myeloid cell lines. Unlike C/EBP alpha, C/EBP epsilon dramatically up-regulated p27 with a concomitant down-regulation of cdk4/6 and cyclin D2/A/E. Moreover, the anti-apoptotic proteins Bcl-2 and Bcl-x were down-regulated, whereas pro-apoptotic protein Bax remained unchanged. Using a variety of mutants, we revealed that these events were all regulated by the N-terminal activation domain of C/EBP epsilon. Interestingly, some of the differentiation processes such as the induction of secondary granule protein genes were clearly inhibited by c-Myc; however, inhibition of apoptosis by Bcl-x did not affect the entire differentiation processes. These data indicate the N terminus of C/EBP epsilon to be solely responsible for most aspects of myeloid differentiation, and these events were differentially affected by c-Myc.
引用
收藏
页码:14494 / 14502
页数:9
相关论文
共 34 条
[1]   STAT3-mediated differentiation and survival of myeloid cells in response to granulocyte colony-stimulating factor:: role for the cyclin-degendent kinase inhibitor p27Kip1 [J].
de Koning, JP ;
Soede-Bobok, AA ;
Ward, AC ;
Schelen, AM ;
Antonissen, C ;
van Leeuwen, D ;
Löwenberg, B ;
Touw, IP .
ONCOGENE, 2000, 19 (29) :3290-3298
[2]  
Dinauer Mary C., 2000, Hematology Am Soc Hematol Educ Program, P303
[3]   A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice [J].
Fero, ML ;
Rivkin, M ;
Tasch, M ;
Porter, P ;
Carow, CE ;
Firpo, E ;
Polyak, K ;
Tsai, LH ;
Broudy, V ;
Perlmutter, RM ;
Kaushansky, K ;
Roberts, JM .
CELL, 1996, 85 (05) :733-744
[4]   C/EBPε interacts with retinoblastoma and E2F1 during granulopoiesis [J].
Gery, S ;
Gombart, AF ;
Fung, YK ;
Koeffler, HP .
BLOOD, 2004, 103 (03) :828-835
[5]   CCAAT/enhancer-binding protein-α cooperates with p21 to inhibit cyclin-dependent kinase-2 activity and induces growth arrest independent of DNA binding [J].
Harris, TE ;
Albrecht, JH ;
Nakanishi, M ;
Darlington, GJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) :29200-29209
[6]   Translational control of p27(Kip1) accumulation during the cell cycle [J].
Hengst, L ;
Reed, SI .
SCIENCE, 1996, 271 (5257) :1861-1864
[7]   Induction of p27(Kip1) degradation and anchorage independence by Ras through the MAP kinase signaling pathway [J].
Kawada, M ;
Yamagoe, S ;
Murakami, Y ;
Suzuki, K ;
Mizuno, S ;
Uehara, Y .
ONCOGENE, 1997, 15 (06) :629-637
[8]   Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1) [J].
Kiyokawa, H ;
Kineman, RD ;
ManovaTodorova, KO ;
Soares, VC ;
Hoffman, ES ;
Ono, M ;
Khanam, D ;
Hayday, AC ;
Frohman, LA ;
Koff, A .
CELL, 1996, 85 (05) :721-732
[9]   Biological role of the CCAAT enhancer-binding protein family of transcription factors [J].
Lekstrom-Himes, J ;
Xanthopoulos, KG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (44) :28545-28548
[10]  
Lekstrom-Himes J, 1999, BLOOD, V93, P3096